Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Alabama at Birmingham Identifier:
First received: December 10, 1999
Last updated: April 10, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2001
  Primary Completion Date: January 2001 (Final data collection date for primary outcome measure)